Ventricular arrhythmias and sudden death events following acalabrutinib initiation
Seema A. Bhat(The Ohio State University), Daniel Addison(The University of Texas Southwestern Medical Center), Tracy Wiczer(The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute), Jennifer A. Woyach(The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute), John Alan Gambril(The Ohio State University Wexner Medical Center), Patrick Ruz(The Ohio State University Wexner Medical Center), Kerry A. Rogers(The Ohio State University), Sujay Kalathoor(University of Washington), Michael R. Grever(The Ohio State University Wexner Medical Center), Leylah Azali(The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute), Farrukh T. Awan(The University of Texas Southwestern Medical Center), Sunnia T. Chen(Mayo Clinic), Adam S. Kittai(Icahn School of Medicine at Mount Sinai), Qiuhong Zhao(The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute), John C. Byrd(University of Cincinnati), Marilly Palettas(The Ohio State University Wexner Medical Center), Lindsay Rosen(The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute)
Cited by 68
Related Papers
Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling
|Nature|2000|9.9k
iwCLL guidelines for diagnosis, indications for treatment, response assessment, and supportive management of CLL
|Blood|2018|1.7k
Relation of Gene Expression Phenotype to Immunoglobulin Mutation Genotype in B Cell Chronic Lymphocytic Leukemia
|The Journal of Experimental Medicine|2001|1.1k
Acalabrutinib (ACP-196) in Relapsed Chronic Lymphocytic Leukemia
|New England Journal of Medicine|2015|890